The Innovation Network Corporation of Japan (INCJ) has led a JPY1.16 billion ($11.7 million) investment in Megakaryon Corp, which is developing technology to produce blood platelets using...
Healthcare | 26 Aug 2013 |
KKR, Toshiba Corp. and a consortium including Bain Capital, Mitsui & Co. and Development Bank of Japan are expected to participate in the final round of bidding for Panasonic’s healthcare unit.
Healthcare | 26 Aug 2013 |
BVCF, a China-focused private equity growth fund specializing in life sciences, has a led a $25 million Series B round for MicuRX Paharmaceuticals, a biopaharma firm developing next generation antibiotics. The round also includes existing backers Morningside...
Venture | 23 Aug 2013 |
The Carlyle Group, Advent International and Mitsui and Co. are among the 10 bidders for Hong Kong’s Quality Healthcare Medical Services, which is being sold by PE-backed Fortis Healthcare.
South Asia | 20 Aug 2013 |
Healthcare-focused private equity firm OrbiMed Advisors is targeting $300 million for its second Asia fund. The PE firm raised $188 million for its debut regional vehicle in 2008.
Fundraising | 19 Aug 2013 |
The Abraaj Group and CDC, the UK government’s development finance arm, have together committed $17.5 million to Rainbow Hospitals, a pediatric and maternity healthcare facility in the southern Indian state of Andhra Pradesh. The size of the stake was...
South Asia | 14 Aug 2013 |
ASK Pravi Capital Advisors has invested INR600 million ($9.7 million) in the tertiary care OMNI Hospitals chain for a significant minority stake.
South Asia | 08 Aug 2013 |
Olympus Capital-backed DM healthcare and Temasek’s HealthCare Global (HCG) are reported to be making offers for Actis Capital's Sterling Hospitals.
South Asia | 05 Aug 2013 |
Malaysian sovereign wealth fund Khazanah Nasional has agreed to pay $252 million for a 90% stake in Turkish health insurer Acibadem Sigorta. The investment facilitates the exit of The Abraaj Group, which held a 50% stake in the business.
Financials | 30 Jul 2013 |
Multiples Alternate Asset Management has bought a 64% stake in Bangalore-based Vikram Hospital from ICICI Venture Funds Management, and also infused direct capital for debt repayment.
South Asia | 26 Jul 2013 |
Standard Chartered Private Equity (SCPE) will invest a further $13.5 million in hospital chain Fortis Healthcare through a preferential allotment of shares, taking its total holding to around 2.7%.
South Asia | 25 Jul 2013 |
Legend Capital has participated in a $62.5 million Series C round of funding for Munich-based JenaValve Technology, a manufacturer of valve systems used to treat heart conditions. The company intends to apply to market products in China.
Greater China | 24 Jul 2013 |
IndiaVenture Advisors (IVA), the PE arm of Indian healthcare company Piramal Enterprises, expects to reach a first close at around INR1.5 billion ($25 million) next month on IndiaVenture Trust Fund II, which has a full target of INR10 billion.
South Asia | 22 Jul 2013 |
Driven by government policy, China's medical devices industry is growing rapidly and VC capital is flowing in. Picking winners requires a keen eye for new technology and potential distribution obstacles
Greater China | 17 Jul 2013 |
Riverside has acquired a controlling interest in Hamilton-based animal drug delivery company Simcro for a undisclosed sum.
Buyouts | 12 Jul 2013 |
Updating your subscription status
Join us at the 11th Annual AVCJ Private Equity & Venture Australia and New Zealand Forum on 5-7 March at the Four Seasons Hotel in Sydney to find out how funds of varying size are raising capital, sourcing deals and exits, as well as all you need to know to effectively navigate Australasia's changing alternative asset landscape.
After a decade-long mining boom the economy is experiencing a loss of momentum and the resulting deal flow reduction and lack of value in the market means GPs are chasing many of the same acquisition targets. That said, the exit market is recovering with both IPOs and M&A activity picking up, and an increase in LPs appetite for the asset class, and the recent government change means that the industry is cautiously optimistic for the future and expecting a rise in activity over the next 12 months.
5-7 March 2014, Four Seasons Hotel, Sydney